About us
Serein Tangle is an independent resource on ibogaine and depression, examining emerging research, policy, uncertainty, and safety concerns. It exists to help people make sense of a fast-changing, high-risk topic without overstating what is known.
Context before conclusions.
Built for the parts that do not fit on a brochure.
We organize information around the questions people actually face: what is established, what is emerging, what remains uncertain, and where caution is warranted. The material is structured so readers can return to the wider ibogaine and depression context without being pushed toward a conclusion.
Our approach draws on published literature, research registries, and official sources. Clinical-trial records can be checked through the ClinicalTrials.gov database, while medication-safety framing is informed by sources such as the FDA drug safety information. Sources are useful evidence, not endorsements.
A map of questions, rather than a sales pitch.
Evidence firstSerein Tangle keeps distinct topics distinct: evidence, safety, policy, access, and uncertainty. That structure is intentional. It helps readers see where one question ends and another begins, including when examining material about ibogaine HCl information.
The site also makes room for adjacent questions that can otherwise blur together, such as how people assess what an ibogaine treatment involves and how treatment-center claims should be read. Our topic pathways and resource scope explain how those strands are organized without presenting a referral or treatment service.
Source before certainty.
We aim to identify the type and limits of each source rather than flattening everything into a single answer. Research summaries, government materials, and primary records do different jobs. That distinction matters when claims are emotionally significant or commercially persuasive.
For broader public-health context, we look to established institutional material such as the National Institutes of Health health information. We also note when a subject belongs to another area of inquiry, including discussions of ibogaine treatment and Parkinson’s, rather than treating it as evidence for a different question.
“The useful answer is sometimes: the evidence is incomplete, the risk is real, and the next question matters.”
What guides the work.
- Independence from clinics, providers, and treatment centers.
- Evidence before hype, including clear source limits.
- Risk transparency without sensationalism.
- Plain language for complex material.
- Respect for complexity when evidence does not settle a question.
For people looking for steadier footing.
This resource is for people affected by depression, families, veterans, advocates, and others seeking careful context on ibogaine-related developments. It is not designed to decide for anyone. It is designed to make underlying questions easier to recognize and investigate.
People may encounter claims connected to ibogaine treatment centers in Mexico while trying to orient themselves. Serein Tangle does not rank, recommend, verify, or represent treatment centers. It provides context so readers can distinguish information from promotion.
Anyone wanting the broader framing can begin with the resource’s central overview, then move through the site by the question most relevant to them. That is also why we link policy, evidence, and safety material as separate paths instead of treating them as interchangeable.
No referral agenda. No promised outcome.
Serein Tangle is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. The purpose is careful orientation: clear sourcing, plain language, and appropriate limits.
Reach the contact page